Charles River Laboratories | Actif À Court Terme



Current Assets Changement Date
Agilent USD 4.11B 148M 2025-01
Align Technology USD 2.4B 90.41M 2025-03
Bio-Rad Laboratories USD 3.04B 6.3M 2025-03
Bruker USD 2.06B 133.1M 2024-12
Cardinal Health USD 34.6B 1.16B 2025-03
Charles River Laboratories USD 1.4B 91.65M 2024-12
Cigna USD 43.56B 5.32B 2025-03
CVS Health USD 73.19B 4.55B 2025-03
Danaher USD 9.52B 28M 2025-03
Dentsply International USD 1.75B 175M 2024-12
Elevance Health 58.73B 4.12B 2024-12
Galapagos EUR 3.47B 132.9M 2025-03
Hologic USD 3.21B 284.9M 2025-03
Humana USD 29.82B 3.11B 2024-12
Illumina USD 2.75B 373M 2024-12
Incyte USD 3.23B 7.24M 2025-03
IQVIA Holdings USD 5.91B 82M 2025-03
Laboratory Of America USD 3.79B 1.02B 2025-03
Lonza CHF 5.44B 113M 2024-12
McKesson USD 51.74B 1.6B 2024-12
Merck EUR 13.45B 479M 2024-12
Mettler Toledo International USD 1.16B 29.11M 2025-03
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 45.86B 4.5B 2025-03
Quest Diagnostics USD 2.08B 317M 2025-03
Revvity USD 2.32B 31.67M 2025-03
Thermo Fisher Scientific USD 23.38B 1.24B 2025-03
United Therapeutics USD 3.94B 65.9M 2025-03
UnitedHealth 85.78B 6.48B 2024-12
Walgreens Boots Alliance USD 16.24B 1.24B 2025-02
Waters USD 1.74B 70.77M 2025-03
West Pharmaceutical Services USD 1.46B 80.6M 2025-03



Charles River Laboratories Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.